On December 7, the State Council issued the Notice on Further Optimizing and Implementing the Prevention and Control Measures for the novel coronavirus Pneumonia Epidemic Situation by the Comprehensive Team of the Joint Prevention and Control Mechanism for the COVID-19. With the adjustment of epidemic prevention and control measures in various regions, the demand of citizens for drugs and medical devices such as Lianhua Qingwen, anti-virus oral liquid, Ganmaoling, antigen detection kit, etc. has increased, and some drugs are out of stock and have increased in price. On the same day, the author visited various pharmacies in Guangzhou and found that the pharmacies on the market had stepped up the supply of related drugs. The Guangdong Provincial Market Supervision and Administration Bureau issued a circular on regulating the market price behavior of drugs and medical devices (hereinafter referred to as the "circular"), which requires drug and medical device operators and relevant units across the province not to fabricate or disseminate information about price increases, hoard and store curiosities, drive up prices, and promote excessive price increases. Some pharmacies on the market are stepping up the supply of medicines and medical devices, such as Lianhua Qingwen, anti-virus oral liquid, Ganmaoling, antigen detection kit, etc., which are concerned by many citizens at present. "It's just a temporary shortage. Recently, the sales volume of epidemic prevention commodities in Guangdong has increased by 50% compared with the past. The citizens mainly buy medicines for standby." The relevant person in charge of Dashanlin said that at present, it is increasing the drug inventory, especially the epidemic prevention commodities, and the purchase plan is made according to the conventional 2-3 times, to ensure smooth logistics. The circular pointed out that drug and medical device operators and relevant units in the province should establish and improve the internal price management system, accurately record and verify the production and operation costs, and should not increase the sales prices of drugs and medical devices such as Lianhua Qingwen, anti-virus oral liquid, Ganmaoling, antigen detection kit, etc. without significant increase in production and operation costs. In addition, we should effectively implement the system of clearly marked prices. We should not sell goods at a higher price than the marked prices, and should not charge any unspecified fees. The circular also pointed out that drug and medical device operators and relevant units in the province should not fabricate and disseminate information about price increases, hoard and hoard, drive up prices, and push commodity prices too high; They shall not collude with each other to manipulate market prices and damage the legitimate rights and interests of other operators or consumers. According to laws and regulations such as the Price Law and the Provisions on Administrative Penalties for Price Violations, operators who commit price fraud can be fined up to 500000 yuan; A fine of up to 3 million yuan may be imposed on those who fabricate and spread information about price increases, drive up prices, hoard commodities, and push commodity prices up too fast or too high; For those who collude with each other and manipulate market prices, resulting in a large increase in commodity prices, a fine of up to 5 million yuan may be imposed. Those suspected of committing crimes will be transferred to the judicial authorities. (Liu Xinshe)